Organosyn lifesciences ltd

VORITAB®-200 - Organosyn
  • Type of the medical product: Antifungal drugs for systemic use
  • Pharmaceutical form: Film-coated tablets
  • Composition: 1 film-coated tablet contains 200 mg of voriconazole
  • Indication:

    Prevention of invasive fungal infections during allogeneic bone marrow transplantation in patients with a high risk of this complication.

    Treatment of adults and children with:

    -      invasive aspergillosis;

    -      candidemia not accompanied by neutropenia;

    -      severe invasive infections caused by Candida (including C. krusei), resistant to fluconazole;

    -      severe fungal infections caused by Scedosporium and Fusarium species.

    As initial therapy in patients with progressive, potentially life-threatening infections.